For the integrated multidisciplinary approach to patient care

Return to the Southern Medical Journal

Current User S2 Access Level: -1 ()
CAN NOT ACCESS LEVEL 2
Original Article

The Effect of July Admission in the Process of Care of Patients with Acute Cardiovascular Conditions

Santiago Garcia MD, Mariana Canoniero MD, Larry Young MD
Volume: 102 Issue: 6 June, 2009

Abstract:

Background:Little information is available to measure the impact of new trainees in the process of care and outcomes of patients with acute cardiovascular conditions. The objective of this investigation is to assess whether physicians' experience has an impact on the quality of health care delivery.Methods:Two cohorts of hospitalized patients with acute coronary syndromes (ACS) (n = 764) and decompensated heart failure (HF) (n = 590) were included in this study. Utilization of life-saving medications, diagnostic and therapeutic procedures, and in-hospital outcomes were compared between patients admitted during July—September (J-S) vs. October—June (O-J). Independent predictors of optimal medical management (OMM) were determined by logistic regression analysis.Results:During O—J, 573 (75%) patients were admitted with an ACS and 516 (84%) with decompensated HF. Among patients with acute coronary syndromes, utilization of beta blockers, aspirin, and statins was similar in the two groups (all P NS). In multivariate analysis, the only independent predictor of optimal medical management was the performance of coronary angioplasty (OR = 1.5, 95% CI = 1.05–2.14, P = 0.02). Among patients with decompensated HF, no difference was found in utilization of beta blockers, ACEI/ARB, length of stay and in-hospital mortality. In multivariate analysis, age >65, atrial fibrillation, admission during J—S, and disease severity were all independent predictors of not receiving optimal medical management (all P < 0.05). These differences were explained exclusively on the basis of EF measurement and not on different utilization rates of pharmacological therapy.Conclusions:Our results do not support the concept of a “July phenomenon” in patients presenting with acute cardiovascular conditions.

Article:

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Member Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

Images:

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Member Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

References:

References1. Brotherton SE, Rockey PH, Etzel SI. US graduate medical education, 2002–2003. JAMA 2003;290:1197–1202.BrothertonSE]]RockeyPH]]EtzelSIUS graduate medical education, 2002–2003.JAMA20032901197-12022. Rich EC, Gifford G, Luxenburg M, et al. The relationship of house staff experience to the cost and quality of inpatient care. JAMA 1990;263:953–957.RichEC]]GiffordG]]LuxenburgM&etal;The relationship of house staff experience to the cost and quality of inpatient care.JAMA1990263953-9573. Rich EC, Hillson SD, Dowd B, et al. Specialty differences in the “July Phenomenon” for twin cities teaching hospitals. Med Care 1993;31:73–83.RichEC]]HillsonSD]]DowdB&etal;Specialty differences in the “July Phenomenon” for twin cities teaching hospitals.Med Care19933173-834. Shulkin DJ. The July phenomenon revisited: Are hospital complications associated with new house staff? Am J Med Qual 1995;10:14–17.ShulkinDJThe July phenomenon revisited: Are hospital complications associated with new house staff?Am J Med Qual19951014-175. Chow KM, Szeto CC, Chan MH, et al. Near-miss errors in laboratory blood test requests by interns. QJM 2005;98:753–756.ChowKM]]SzetoCC]]ChanMH&etal;Near-miss errors in laboratory blood test requests by interns.QJM200598753-7566. Park SJ, Tector A, Piccioni W, et al. LVAD as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005;129:9–17.ParkSJ]]TectorA]]PiccioniW&etal;LVAD as destination therapy: a new look at survival.J Thorac Cardiovasc Surg20051299-177. Zuger A. Essay; it's July, the greenest month in Hospitals. No need to panic. Available at: http://query.nytimes.com/gst/fullpage.html?res=9E0DE6DF133EF934A35754C0A96E958260&scp=1&sq=july+phenomenon+hospitals&st=nyt. Accessed on June 2, 2008.8. Friedman R. Cases; their coats are white, but their hands are green. Available at: http://query.nytimes.com/gst/fullpage.html?res=980DE0DA1438F93AA15755C0A9629C8B63&scp=2&sq=july+phenomenon+hospitals&st=nyt. Accessed on June 2, 2008.9. Finkielman JD, Morales J, Peters SG, et al. Mortality rate and length of stay of patients admitted to the intensive care unit. Crit Care Med 2004;32:1161–1165.FinkielmanJD]]MoralesJ]]PetersSG&etal;Mortality rate and length of stay of patients admitted to the intensive care unit.Crit Care Med2004321161-116510. Barry WA, Rosenthal GE. Is there a July phenomenon? The effects of July admission on intensive care mortality and length of stay in teaching hospitals. J Gen Intern Med 2003;18:639–645.BarryWA]]RosenthalGEIs there a July phenomenon? The effects of July admission on intensive care mortality and length of stay in teaching hospitals.J Gen Intern Med200318639-64511. Garcia S, Canoniero M, Peter A, et al. Correlation of TIMI Risk score with angiographic severity and extent of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes. Am J Cardiol 2004;93:813–816.GarciaS]]CanonieroM]]PeterA&etal;Correlation of TIMI Risk score with angiographic severity and extent of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes.Am J Cardiol200493813-81612. Osorio J, Garcia S, Jimenez J. Cardiologists vs. Generalists in the management of acutely decompensated heart failure. J Card Fail 2005;11(suppl):S180.OsorioJ]]GarciaS]]JimenezJCardiologists vs. Generalists in the management of acutely decompensated heart failure.J Card Fail200511S18013. Antman E, Cohen M, Berninck P, et al. The TIMI risk score for unstable/non-ST elevation MI. A method for prognostication and Therapeutic Decision Making. JAMA 2000;284:835–842.AntmanE]]CohenM]]BerninckP&etal;The TIMI risk score for unstable/non-ST elevation MI. A method for prognostication and Therapeutic Decision Making.JAMA2000284835-84214. Fonarow GC, Adams KF Jr, Abraham WT, et al; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293:572–580.FonarowGC]]AdamsKFJr]]AbrahamWT&etal;ADHERE Scientific Advisory Committee, Study Group, and InvestigatorsRisk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.JAMA2005293572-58015. Braunwald E, Antman E, Beasley JW, et al. Management of patients with unstable angina and non-ST-segment elevation myocardial infarction update. Available at: http://www.acc.org/clinical/guidelines/unstable/incorporated/index.htm. Accessed on June 2, 2008.16. Hunt SA, Abraham WT, Chin MH, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154–e235.HuntSA]]AbrahamWT]]ChinMH&etal;American College of CardiologyAmerican Heart Association Task Force on Practice GuidelinesAmerican College of Chest PhysiciansInternational Society for Heart and Lung TransplantationHeart Rhythm SocietyACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.Circulation2005112e154-e23517. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001–2007.MERIT-HF Study GroupEffect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).Lancet19993532001-200718. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9–13.CIBIS-II Investigators and CommitteesThe Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.Lancet19993539-1319. Packer M, Coats AJ, Fowler MB, et al; Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651–1658.PackerM]]CoatsAJ]]FowlerMB&etal;Carvedilol Prospective Randomized Cumulative Survival Study GroupEffect of carvedilol on survival in severe chronic heart failure.N Engl J Med20013441651-165820. Packer M, Fowler MB, Roecker EB, et al; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002;106:2194–2199.PackerM]]FowlerMB]]RoeckerEB&etal;Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study GroupEffect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.Circulation20021062194-219921. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429–1435.The CONSENSUS Trial Study GroupEffects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).N Engl J Med19873161429-143522. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asympatomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685–691.The SOLVD InvestigatorsEffect of enalapril on mortality and the development of heart failure in asympatomatic patients with reduced left ventricular ejection fractions.N Engl J Med1992327685-69123. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71–86.Antithrombotic Trialists' CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.BMJ200232471-8624. Nicholls SJ, Tuzcu EM, Sipahi I, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007;297:499–508.NichollsSJ]]TuzcuEM]]SipahiI&etal;Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.JAMA2007297499-50825. Cannon CP, Steinberg BA, Murphy SA, et al. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48:438–445.CannonCP]]SteinbergBA]]MurphySA&etal;Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.J Am Coll Cardiol200648438-44526. Cannon CP, Battler A, Brindis RG, et al. ACC key elements and data definitions for measuring the clinical management and outcomes of patients with with acute coronary sundromes: a report of the American College of cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114–2130.CannonCP]]BattlerA]]BrindisRG&etal;ACC key elements and data definitions for measuring the clinical management and outcomes of patients with with acute coronary sundromes: a report of the American College of cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).J Am Coll Cardiol2001382114-213027. Fonarow GC, Yancy CW, Heywood JT; ADHERE scientific advisory committee, study group, and investigators. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE registry. Arch Intern Med 2005;165:1469–1477.FonarowGC]]YancyCW]]HeywoodJTADHERE scientific advisory committee, study group, and investigatorsAdherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE registry.Arch Intern Med20051651469-147728. Fonarow GC, LaBresh KA, Yancy CY, et al for the GWTG Steering Committee and Hospitals. Influence of the American heart Association's Get with the Guidelines heart failure (GWTG-HF) program on emerging performance measures for patients hospitalized with heart failure. Circulation 2006;114(suppl 2):572.FonarowGC]]LaBreshKA]]YancyCY&etal;for the GWTG Steering Committee and HospitalsInfluence of the American heart Association's Get with the Guidelines heart failure (GWTG-HF) program on emerging performance measures for patients hospitalized with heart failure.Circulation200611457229. Albert NM, Birtcher KK, Cannon CP, et al. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the get with the guidelines database). Am J Cardiol 2008;101:1242–1246.AlbertNM]]BirtcherKK]]CannonCP&etal;Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the get with the guidelines database).Am J Cardiol20081011242-124630. Hiratzka LF, Eagle KA, Liang L, et al; Get with the Guidelines Steering Committee. Atherosclerosis secondary prevention performance measures after coronary bypass surgery compared with percutaneous catheter intervention and nonintervention patients in the Get with the Guidelines database. Circulation 2007;116(11 suppl):I207–I212.HiratzkaLF]]EagleKA]]LiangL&etal;Get with the Guidelines Steering CommitteeAtherosclerosis secondary prevention performance measures after coronary bypass surgery compared with percutaneous catheter intervention and nonintervention patients in the Get with the Guidelines database.Circulation2007116I207-I212

CME:

Portions of this issue may be available for CME credit. Please email education@sma.org for a complete listing of current Southern Medical Journal activities, as well as other SMA educational offerings.

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Member Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Member Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

Permissions